The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

New England Journal of Medicine

Volumn 323, Issue 25, 1990, Pages 1740-1744

  Israel, Elliot ^a,b   Dermarkarian, Robert ^a,b   Rosenberg, Mitchell ^a   Sperling, Richard ^b   Taylor, Graham ^e   Rubin, Paul ^d   Drazen, Jeffrey M ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ABBOTT LABORATORIES   (United States)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LIPOXYGENASE INHIBITOR; PLACEBO; ZILEUTON;

ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; COLD AIR; DRUG EFFECT; PRIORITY JOURNAL;

ARACHIDONATE 5-LIPOXYGENASE; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CALCIMYCIN; COLD; DOUBLE-BLIND METHOD; EICOSANOIDS; HUMAN; HUMIDITY; HYDROXYUREA; MALE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025647031     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199012203232505     Document Type: Article

References (33)

1. Holroyde MC, Altounyan REC, Cole M, Dixon M, Elliott EV. Bronchoconstriction produced in man by leukotrienes C and D. Lancet 1981; 2: 17–8.
2. Weiss JW, Drazen JM, Coles N, et al. Bronchoconstrictor effects of leukotriene C in humans. Science 1982; 216: 196–8.
3. Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax 1984; 39: 500–4.
4. Smith LJ, Greenberger PA, Patterson R, Krell RD, Bernstein PR. The effect of inhaled leukotriene D4 in humans. Am Rev Respir Dis 1985; 131: 368–72.
5. Adelroth E, Morris MM, Hargreave FE, O'Byrne PM. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986; 315: 480–4.
6. Marom Z, Shelhamer JH, Sun F, Kaliner M. Human airway monohydroxyeicosatetraenoic acid generation and mucus release. J Clin Invest 1983; 72: 122–7.
7. Marom Z, Shelhamer JH, Bach MK, Morton DR, Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982; 126: 449–51.
8. Martin TR, Altman LC, Albert RK, Henderson WR. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106–11.
9. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264–5.
10. Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988; 81: 711–7.
11. Iikura Y, Nagakura T, Walsh GM, et al. Role of chemical mediators after antigen and exercise challenge in children with asthma. J Allergy Clin Immunol 1988; 81: 1050–5.
12. Taylor GW, Taylor I, Black P, et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989; 1: 584–8.
13. Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory disease. J Allergy Clin Immunol 1989; 84: 19–26.
14. Pliss LB, Ingenito EP, Ingram RH Jr, Pichurko B. Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma. Am Rev Respir Dis 1990; 142: 73–8.
15. Lewis RA. A presumptive role for leukotrienes in obstructive airways diseases. Chest 1985; 88: Suppl 2: 98S–102S.
16. Fujimura M, Sasaki F, Nakatsumi Y, et al. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986; 41: 955–9.
17. Fuller RW, Maltby N, Richmond R, et al. Oral nafazatrom in man: effect on inhaled antigen challenge. Br J Clin Pharmacol 1987; 23: 677–81.
18. Mann JS, Robinson C, Sheridan AQ, Clement P, Bach MK, Holgate ST. Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma. Thorax 1986; 41: 746–52.
19. Carter GW, Young PR, Albert D, et al. Propertiesof A-64077, a new potent orally active 5-lipoxygenase inhibitor. In: Zor U, Naor Z, Danon A, eds. Leukotrienes and prostanoids in health and disease. Vol. 3 of New trends in lipid mediators research. Basel, Switzerland: Karger, 1989:50–5.
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–44.
21. Israel E, Juniper EF, Callaghan J, et al. Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. Am Rev Respir Dis 1989; 140: 1348–53.
22. Deal EC Jr, McFadden ER Jr, Ingram RH Jr, Jaeger JJ. Hyperpnea and heat flux: initial reaction sequence in exercise-induced asthma. J Appl Physiol 1979; 46: 476–83.
23. Heavey DJ, Soberman RJ, Lewis RA, Spur B, Austen KF. Criticall considerations in the development of an assay for sulfidopeptide leukotrienes in plasma. Prostaglandins 1987; 33: 693–708.
24. Murphy RC, Hammarstrom S, Samuelsson B. Leukotriene C: a slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A 1979; 76: 4275–
25. Anderson S, Seale JP, Ferris L, Schoeffel R, Lindsay DA. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol 1979; 64: 612–24.
26. Latimer KM, O'Byrne P, Morris MM, Roberts R, Hargreave FE. Bronchoconstriction stimulated by airway cooling: better protection with combined inhalation of terbutaline sulphate and cromolyn sodium than with either alone. Am Rev Respir Dis 1983; 128: 440–3.
27. O'Byrne PM, Thomson NC, Morris M, Roberts RS, Daniel EE, Hargreave FE. The protective effect of inhaled chlorpheniramine and atropine on bronchoconstriction induced by airway cooling. Am Rev Respir Dis 1983; 128: 611–7.
28. Merland N, Cartier A, L'Archeveque J, Ghezzo H, Malo JL. Theophylline minimally inhibits bronchoconstriction induced by dry cold air inhalation in asthmatic subjects. Am Rev Respir Dis 1988; 137: 1304–8.
29. Malo PE, Wiley YD, Shaughnessy TK, et al. Inhibition of antigen-induced contractions of guinea-pig tracheal strips (GPTS) by lipoxygenase (5-LO) inhibitors. Am Rev Respir Dis 1989; 139: Suppl: A92. abstract.
30. Drazen JM. Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects. Ann N Y Acad Sci 1988; 524: 289–97.
31. McFadden ER Jr. Respiratory heat and water exchange: physiological and clinical implications. J Appl Physiol 1983; 54: 331–61.
32. Hahn A, Anderson SD, Morton AR, Black JL, Fitch KD. A reinterpretation of the effect of temperature and water content of the inspired air in exercise-induced asthma. Am Rev Respir Dis 1984; 130: 575–9.
33. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma: new insights into pathophysiology and possible pathogenesis. J Clin Invest 1986; 78: 18–25.